Daniel Marquez
Family · Pueblo, CONPI 1154898914
Payments from drug & device makers
Across 34 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$284
- Gilead$92
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$90
- Indivior Inc.$41
- Viiv Healthcare Company$32
- Organon$17
- plus $73 from 5 others
What the payments were for
- Food & beverage$629100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $284 |
| Gilead | 4 | $92 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $90 |
| Indivior Inc. | 2 | $41 |
| Viiv Healthcare Company | 2 | $32 |
| Organon | 1 | $17 |
| Amgen | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Insulet Corporation | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$629 in reported general payments places this provider in the 70th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tresiba Flextouch U-100Insulin Degludec | 12 | $5,909 |
| Xtampza ErOxycodone Myristate | 12 | $4,412 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,387 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $991 |
| Gabapentin | 35 | $803 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $642 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $639 |
| Atorvastatin Calcium | 66 | $540 |
| Cyclobenzaprine Hcl | 12 | $512 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $441 |
| Omeprazole | 22 | $394 |
| Lisinopril | 56 | $364 |
| Levothyroxine Sodium | 31 | $325 |
| Tizanidine Hcl | 13 | $306 |
| Metformin Hcl | 37 | $304 |
Paid to pharmacies, not to this prescriber.
Other family in Pueblo
- Lisa CloughPueblo$7K
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.